Caldic Denmark A/S: Financial statements 2013
CVR: 32478980
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
Caldic Denmark A/S (CVR 32478980) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 8,008,000 and a net result of DKK 1,074,000 compared with DKK -553,373 the year before. That is an increase of 32% compared with the year before. Equity in the 2013 report amounted to DKK 4,346,000. The solvency ratio was 31.8%.
- Gross Profit
- DKK 8,008,000
- Profit/Loss
- DKK 1,074,000
- Equity
- DKK 4,346,000
- Total Assets
- DKK 13,662,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | 8 mio. | 1.1 mio. | 4.3 mio. | - |
| 2012 | - | 6.1 mio. | -553 t. | 3.3 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
Caldic Denmark A/S has published its annual report for 2012. Gross profit came to DKK 6,065,928, and the net result was DKK -553,373.
On January 14, 2013, the company changed its name from R2 PHARMACTIVE A/S to R2 GROUP PHARMACEUTICALS A/S.
About Caldic Denmark A/S
Caldic Denmark A/S is a Danish company of the type Aktieselskab based in Hedensted, founded in 2009. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named R2 GROUP PHARMACEUTICALS A/S and R2 PHARMACTIVE A/S. The management consists of Peter Kristian Faaborg-Andersen. The board consists of Torsten Walz (chair), Kasper Østergaard, Martin Zemp and Peter Kristian Faaborg-Andersen. The company is owned by Caldic BV. The company has 8 employees (2026). In 2025, the company reported revenue of DKK 76,504,000 and a net result of DKK 4,668,000 compared with DKK 7,712,000 the year before. Equity in the 2025 report amounted to DKK 24,026,000.